Skip to main content
OpenTrials

Clinical trial condition

Uterine Diseases

Explore clinical trials studying Uterine Diseases. Study availability and eligibility vary by location and protocol.

3,093 public trials 702 recruiting studies
Refine in advanced search Browse all conditions

Uterine Diseases trial results

Recruiting

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

NCT07227168

Conditions
Cervical Cancer, Colonic Diseases, Colorectal Cancer, +34 more
Locations
  • SCRI Denver Denver, Colorado, United States
  • SCRI FCS Sarasota Sarasota, Florida, United States
  • Mass General Cancer Center Boston, Massachusetts, United States
  • NEXT Austin Austin, Texas, United States
View Trial Details
Recruiting

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

NCT05150691

Conditions
Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +45 more
Locations
  • Helios Clinical Research Cerritos, California, United States
  • California Research Institute Los Angeles, California, United States
  • Sharp Memorial Hospital San Diego, California, United States
  • Washington Cancer Institute at MedStar Washington Hospital Center Washington D.C., District of Columbia, United States
View all 102 locations
View Trial Details
Recruiting

Endometrial Cancer Vaginal Fluid Specimen Collection Study

NCT07544680

Conditions
Abnormal Uterine Bleeding (AUB), Atypical Endometrial Hyperplasia, Endometrial Cancer, +21 more
Locations
  • Murfreesboro Medical Clinic Murfreesboro, Tennessee, United States
  • Physical Care Clinical Research Sarasota, Florida, United States
  • MaineHealth Scarborough, Maine, United States
  • IC Research Murfreesboro, Tennessee, United States
View Trial Details
Recruiting

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

NCT07383506

Conditions
Advanced Solid Tumors, Adult, Breast Diseases, Breast Neoplasms, +18 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • Washington University School of Medicine - Siteman Cancer Center St Louis, Missouri, United States
  • NEXT Austin Austin, Texas, United States
  • NEXT Virginia Fairfax, Virginia, United States
View Trial Details
Recruiting

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

NCT06276491

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +27 more
Locations
  • City of Hope Duarte, California, United States
  • Stanford Palo Alto, California, United States
  • University of California San Francisco, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 22 locations
View Trial Details
Recruiting

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

NCT04851119

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +90 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
View all 21 locations
View Trial Details
Recruiting

An Exploratory Study on the Efficacy and Safety of Enlonstobart Combined With Concurrent Radiotherapy and Chemotherapy Following Induction Therapy With Enlonstobart Plus Chemotherapy in Patients With Locally Advanced Cervical Cancer.

NCT07776821

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +10 more
Locations
  • Tianjin Cancer Hospital Airport Branch Tianjin, China
  • Tianjin Medical University Cancer Institute and Hospital Tianjin, China
View Trial Details

Related conditions